Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy
出版年份 2014 全文链接
标题
Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 5, Pages 599-610
出版商
Informa Healthcare
发表日期
2014-03-05
DOI
10.1517/13543784.2014.895323
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pazopanib Inhibits the Activation of PDGFRβ-Expressing Astrocytes in the Brain Metastatic Microenvironment of Breast Cancer Cells
- (2013) Brunilde Gril et al. AMERICAN JOURNAL OF PATHOLOGY
- Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer
- (2013) Giuseppe Curigliano et al. BREAST
- A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer
- (2013) Stephen R. D. Johnston et al. BREAST CANCER RESEARCH AND TREATMENT
- A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer
- (2013) Erica L. Mayer et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
- (2013) F. Andre et al. CLINICAL CANCER RESEARCH
- Therapeutic targeting of platelet-derived growth factor receptors in solid tumors
- (2013) Monika Ehnman et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial
- (2013) José Baselga et al. Trials
- Contrasting effects of sunitinib within in vivo models of metastasis
- (2012) Jonathan C. Welti et al. ANGIOGENESIS
- Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer
- (2012) M. T. Weigel et al. ANNALS OF ONCOLOGY
- Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer
- (2012) Jonas Bergh et al. BREAST
- Phase II open-label study of sunitinib in patients with advanced breast cancer
- (2012) Denise A. Yardley et al. BREAST CANCER RESEARCH AND TREATMENT
- Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers
- (2012) Libero Santarpia et al. BREAST CANCER RESEARCH AND TREATMENT
- Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway
- (2012) Vesselina G. Cooke et al. CANCER CELL
- An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors
- (2012) Hajime Asahina et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer
- (2012) William J. Gradishar et al. EUROPEAN JOURNAL OF CANCER
- Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors
- (2012) Maja J. A. de Jonge et al. INVESTIGATIONAL NEW DRUGS
- Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer
- (2012) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors
- (2012) Alicia S Chung et al. JOURNAL OF PATHOLOGY
- Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression
- (2011) Newton J. Hurst et al. BIOCHEMICAL JOURNAL
- Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer
- (2011) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- RETRACTED ARTICLE: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways
- (2010) Aamir Ahmad et al. BREAST CANCER RESEARCH AND TREATMENT
- Pazopanib Reveals a Role for Tumor Cell B-Raf in the Prevention of HER2+ Breast Cancer Brain Metastasis
- (2010) B. Gril et al. CLINICAL CANCER RESEARCH
- The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
- (2010) Zhiwei Wang et al. CURRENT DRUG TARGETS
- Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases
- (2010) Maximilian Merz et al. EUROPEAN JOURNAL OF CANCER
- Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors
- (2010) A. R. Tan et al. ONCOLOGIST
- A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium
- (2010) S. K. Taylor et al. ONCOLOGIST
- Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer
- (2009) Janna Paulsson et al. AMERICAN JOURNAL OF PATHOLOGY
- An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer
- (2009) M. Kozloff et al. ANNALS OF ONCOLOGY
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
- (2009) Yongping Crawford et al. CANCER CELL
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Phase I Trial of Pazopanib in Patients with Advanced Cancer
- (2009) H. I. Hurwitz et al. CLINICAL CANCER RESEARCH
- Pazopanib: therapeutic developments
- (2009) Suwicha Limvorasak et al. EXPERT OPINION ON PHARMACOTHERAPY
- Imatinib mesylate (Gleevec(R)) in advanced breast cancer-expressing C-Kit or PDGFR- : clinical activity and biological correlations
- (2008) M. Cristofanilli et al. ANNALS OF ONCOLOGY
- PDGF-BB is a Novel Prognostic Factor in Colorectal Cancer
- (2008) Yoshito Nakamura et al. ANNALS OF SURGICAL ONCOLOGY
- Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer
- (2008) Louis Wing-Cheong Chow et al. CANCER LETTERS
- Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
- (2008) D. D. Hu-Lowe et al. CLINICAL CANCER RESEARCH
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2008) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting
- (2008) Kristian Pietras et al. PLOS MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started